From €2254EUR$2,500USD£1,936GBP
- Report
- June 2026
Brazil
From €2254EUR$2,500USD£1,936GBP
- Report
- June 2026
Argentina
From €2254EUR$2,500USD£1,936GBP
- Report
- August 2024
- 80 Pages
Global
From €3500EUR$4,159USD£3,112GBP
The Cytomegalovirus Drug market is a subset of the Infectious Diseases Drugs market. It is composed of drugs used to treat cytomegalovirus (CMV) infections, a type of virus that can cause serious health problems in people with weakened immune systems. These drugs are used to reduce the severity of symptoms, prevent complications, and reduce the risk of transmission. Commonly used drugs include ganciclovir, valganciclovir, and foscarnet.
The Cytomegalovirus Drug market is highly competitive, with many companies offering similar products. Some of the major players in the market include Gilead Sciences, Merck & Co., Pfizer, Novartis, and GlaxoSmithKline. Show Less Read more